+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Menopause Market Report 2023-2033

  • PDF Icon

    Report

  • 253 Pages
  • May 2023
  • Region: Global
  • Visiongain
  • ID: 5806115
The Menopause Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Demand for Post-Menopause Drugs Owing to Rise in Geriatric Population

Some of the major forces propelling the menopause and post-menopause market include the aging population, rising awareness, technological advancements, and increasing healthcare spending drive demand for new and innovative solutions. With growing awareness about menopause and its symptoms, more women are seeking treatment options. The aging population is growing worldwide, and it is expected that the number of menopausal women will increase in the coming years. This presents a huge market opportunity for menopause drugs.

Lifestyles changes and sedentary habits have led to an increase in menopausal symptoms as women suffer from symptoms such as insomnia, erratic mood changes and hot flashes. This has led to a rise in demand for menopause drugs that can alleviate these symptoms. With new advancements in drug manufacturing and delivery methods, it is possible to create more effective and targeted menopause drugs with fewer side effects. Moreover, as healthcare expenditures increase globally, more women will have access to menopause drugs, which will drive the market further.

Misconceptions and Associated Side Effect Challenges to Hamper Industry Growth

Menopause is often stigmatized as a taboo subject and inadequately discussed. Women may feel embarrassed and uncomfortable discussing their symptoms, leading to a reluctance to seek treatment openly. Hormonal treatments for menopause may have adverse side effects, such as increased risk of cancer and heart-related problems, leading to safety concerns among patients. In addition to this, menopause products can be costly, making them inaccessible for some women. Health insurance might not be available for these products. Addressing these issues through education, product improvement, pricing strategies, and strategic marketing can significantly boost the growth of menopause products in the market.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the menopause market evolving?
  • What is driving and restraining the menopause market?
  • How will each menopause submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each menopause submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading menopause markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the menopause projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of menopause projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the menopause market?
  • Where is the menopause market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the menopause market today, and over the next 10 years:

  • Our 253-page report provides 109 tables and 154 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the menopause market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising menopause prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Treatment Type Outlook

  • Dietary Supplements
  • OTC Pharma Products
  • Hormonal
  • Non-Hormonal: Anti-depressants, Others

Distribution Channel

  • Retail
  • Online
  • Institutional Sales

Stage

  • Perimenopause
  • Menopause
  • Post-menopause

Route of Administration

  • Topical
  • Oral
  • Injectables
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Menopause Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • Abbott
  • AbbVie Inc.
  • Bayer AG
  • Cipla Inc.
  • Eli Lily
  • Emcure
  • Glenmark Pharmaceuticals Limited
  • Merck
  • Novartis
  • Novo Nordisk
  • Padagis
  • Pure Encapsulations, LLC
  • Teva Pharmaceuticals Limited
  • Theramex
  • TherapeuticsMD
Overall world revenue for Menopause Market, 2023 to 2033 in terms of value the market will surpass US$17.33 billion in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Menopause Market, 2023 to 2033 report help you?

In summary, this 250+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Menopause Market, 2023 to 2033 Market, with forecasts for treatment type, distribution channel, stage, route of administration, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Menopause Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Russia, China, India, Japan, South Korea and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Menopause Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Menopause Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Menopause Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.1.1 The incidence of vasomotor symptoms associated with menopause is on the rise
4.2.1.2 An increase in investment in menopausal treatments
4.2.1.3 The benefits of dietary supplements are becoming increasingly apparent as more and more research is being conducted
4.2.2 Market Restraining Factors
4.2.2.1 Side effects associated with hormone therapy
4.2.2.2 Limited research and development activities
4.2.3 Market Opportunities
4.2.3.1 Start-up companies have a great opportunity
4.2.3.2 Stress and trendy lifestyles have a negative impact on women's health, creating an opportunity for menopause product manufacturer
4.3 COVID-19 Impact Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Supplier Power
4.4.2 Buyer Power
4.4.3 Competitive Rivalry
4.4.4 Threat from Substitutes
4.4.5 Threat of New Entrants
4.5 PESTLE Analysis
5 Menopause Market Analysis by Treatment
5.1 Key Findings
5.2 Treatment Segment Growth Prospects
5.3 Menopause Market Share by Type, 2023, 2028 & 2033
5.4 Dietary supplements
5.4.1 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ Bn)
5.4.2 Dietary Supplements Market Share by Region, 2023-2033 (%)
5.5 OTC Pharma Products
5.5.1 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.2 OTC Pharma Products Market Share by Region, 2023-2033 (%)
5.5.3 Hormonal
5.5.3.1 Hormonal Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.3.2 Hormonal Market Share by Region, 2023-2033 (%)
5.5.4 Non-Hormonal
5.5.4.1 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.4.2 Non-Hormonal Market Share by Region, 2023-2033 (%)
5.5.5 Anti-depressants
5.5.5.1 Anti-depressants Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.5.1.1 Antidepressants Market Share by Region, 2023-2033 (%)
5.5.5.2 Others
5.5.5.2.1 Others Market Forecast by Region, 2023-2033 (US$ Bn)
5.5.5.2.2 Others Market Share by Region, 2023-2033 (%)
6 Menopause Market Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment Growth Prospects
6.3 Menopause Market Share by Distribution Channel, 2023, 2028 & 2033
6.4 Retail
6.4.1 Retail Market Forecast by Region, 2023-2033 (US$ Bn)
6.4.2 Retail Market Share by Region, 2023-2033 (%)
6.5 Institutional Sales
6.5.1 Institutional Sales Market Forecast by Region, 2023-2033 (US$ Bn)
6.5.2 Institutional Sales Market Share by Region, 2023-2033 (%)
6.6 Online
6.6.1 Online Market Forecast by Region, 2023-2033 (US$ Bn)
6.6.2 Online Market Share by Region, 2023-2033 (%)
7 Menopause Market Analysis by Stage
7.1 Key Findings
7.2 Stage Segment Growth Prospects
7.3 Menopause Market Share by Stage, 2023, 2028 & 2033
7.4 Perimenopause
7.4.1 Perimenopause Market Forecast by Region, 2023-2033 (US$ Bn)
7.4.2 Perimenopause Market Share by Region, 2023-2033 (%)
7.5 Menopause
7.5.1 Menopause Market Forecast by Region, 2023-2033 (US$ Bn)
7.5.2 Menopause Market Share by Region, 2023-2033 (%)
7.6 Post menopause
7.6.1 Post menopause Market Forecast by Region, 2023-2033 (US$ Bn)
7.6.2 Post Menopause Market Share by Region, 2023-2033 (%)
8 Menopause Market Analysis by Route of Administration
8.1 Key Findings
8.2 Route of Administration Segment Growth Prospects
8.3 Menopause Market Share by Distribution Channel, 2023, 2028 & 2033
8.4 Topical
8.4.1 Topical Market Forecast by Region, 2023-2033 (US$ Bn)
8.4.2 Topical Market Share by Region, 2023-2033 (%)
8.5 Injectable
8.5.1 Injectable Market Forecast by Region, 2023-2033 (US$ Bn)
8.5.2 Injectable Market Share by Region, 2023-2033 (%)
8.6 Oral
8.6.1 Oral Market Forecast by Region, 2023-2033 (US$ Bn)
8.6.2 Oral Market Share by Region, 2023-2033 (%)
9 Menopause Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
10 North America Menopause Market Analysis
10.1 Key Findings
10.2 North America Menopause Market Attractiveness Index
10.3 North America Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
10.4 North America Menopause Market Size Estimation and Forecast by Country
10.5 North America Menopause Market Size Estimation and Forecast by Treatment
10.6 North America Menopause Market Size Estimation and Forecast by Distribution Channel
10.7 North America Menopause Market Size Estimation and Forecast by Stage
10.8 North America Menopause Market Size Estimation and Forecast by Route of Administration
10.9 U.S. Menopause Market Analysis
10.10 Canada Menopause Market Analysis
11 Europe Menopause Market Analysis
11.1 Key Findings
11.2 Europe Menopause Market Attractiveness Index
11.3 Europe Menopause Market by Country, 2023, 2028 & 2033 (US$ Bn)
11.4 Europe Menopause Market Size Estimation and Forecast by Country
11.5 Europe Menopause Market Size Estimation and Forecast by Treatment
11.6 Europe Menopause Market Size Estimation and Forecast by Distribution Channel
11.7 Europe Menopause Market Size Estimation and Forecast by Stage
11.8 Europe Menopause Market Size Estimation and Forecast by Route of Administration
11.9 UK Menopause Market Analysis
11.10 Germany Menopause Market Analysis
11.11 France Menopause Market Analysis
11.12 Italy Menopause Market Analysis
11.13 Spain Menopause Market Analysis
11.14 Russia Menopause Market Analysis
11.15 Rest of Europe Menopause Market Analysis
12 Asia Pacific Menopause Market Analysis
12.1 Key Findings
12.2 Asia Pacific Menopause Market Attractiveness Index
12.3 Asia Pacific Menopause Market by Country, 2023, 2028 & 2033 (US$ Bn)
12.4 Asia Pacific Menopause Market Size Estimation and Forecast by Country
12.5 Asia Pacific Menopause Market Size Estimation and Forecast by Treatment
12.6 Asia Pacific Menopause Market Size Estimation and Forecast by Distribution Channel
12.7 Asia Pacific Menopause Market Size Estimation and Forecast by Stage
12.8 Asia Pacific Menopause Market Size Estimation and Forecast by Route of Administration
12.9 Japan Menopause Market Analysis
12.10 China Menopause Market Analysis
12.11 India Menopause Market Analysis
12.12 Australia Menopause Market Analysis
12.13 South Korea Menopause Market Analysis
12.14 Rest of Asia Pacific Menopause Market Analysis
13 Latin America Menopause Market Analysis
13.1 Key Findings
13.2 Latin America Menopause Market Attractiveness Index
13.3 Latin America Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
13.4 Latin America Menopause Market Size Estimation and Forecast by Country
13.5 Latin America Menopause Market Size Estimation and Forecast by Treatment
13.6 Latin America Menopause Market Size Estimation and Forecast by Distribution Channel
13.7 Latin America Menopause Market Size Estimation and Forecast by Stage
13.8 Latin America Menopause Market Size Estimation and Forecast by Route of Administration
13.9 Brazil Menopause Market Analysis
13.10 Mexico Menopause Market Analysis
13.11 Argentina Menopause Market Analysis
13.12 Rest of Latin America Menopause Market Analysis
14 MEA Menopause Market Analysis
14.1 Key Findings
14.2 MEA Menopause Market Attractiveness Index
14.3 MEA Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
14.4 MEA Menopause Market Size Estimation and Forecast by Country
14.5 MEA Menopause Market Size Estimation and Forecast by Treatment
14.6 MEA Menopause Market Size Estimation and Forecast by Distribution Channel
14.7 MEA Menopause Market Size Estimation and Forecast by Stage
14.8 MEA Menopause Market Size Estimation and Forecast by Route of Administration
14.9 GCC Menopause Market Analysis
14.10 South Africa Menopause Market Analysis
14.11 Rest of MEA Menopause Market Analysis
15 Competitive Landscape
15.1 Company Share Analysis
15.2 Strategic Outlook
16 Company Profiles
16.1 Theramex
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Product Benchmarking
16.1.4 Strategic Outlook
16.2 AbbVie Inc.
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.3.1 Net Revenue, 2019-2021
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Bayer AG
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2018-2021
16.3.4 Product Benchmarking
16.4 Cipla Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2019-2022
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 TherapeuticsMD
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2020-2021
16.5.4 Product Benchmarking
16.5.5 Strategic Outlook
16.6 Eli Lilly and Company
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.3.1 Net Revenue, 2019-2021
16.6.4 Product Benchmarking
16.7 Emcure
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2019-2021
16.7.4 Product Benchmarking
16.8 Glenmark Pharmaceuticals Limited
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2019-2022
16.8.4 Product Benchmarking
16.8.5 Strategic Outlook
16.9 Merck & Co., Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.3.1 Net Revenue, 2019-2021
16.9.4 Product Benchmarking
16.10 Novartis AG
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.3.1 Net Revenue, 2020-2022
16.10.4 Product Benchmarking
16.11 Novo Nordisk A/S
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.3.1 Net Revenue, 2019-2022
16.11.4 Product Benchmarking
16.12 Pure Encapsulations, LLC
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.13 Padagis
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Product Benchmarking
16.14 Teva Pharmaceutical Industries Ltd.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.3.1 Net Revenue, 2019-2021
16.14.4 Product Benchmarking
16.14.5 Strategic Outlook
16.15 Abbott
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.3.1 Net Revenue, 2019-2021
16.15.4 Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks from
17.2 Recommendations for Market Players

Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • Bayer AG
  • Cipla Inc.
  • Eli Lily
  • Emcure
  • Glenmark Pharmaceuticals Limited
  • Merck
  • Novartis
  • Novo Nordisk
  • Padagis
  • Pure Encapsulations, LLC
  • Teva Pharmaceuticals Limited
  • Theramex
  • TherapeuticsMD
  • Amgen
  • Elvie
  • Fitbit Inc.
  • Flo Health Inc.
  • GVK Biosciences Private Limited
  • MEDPACE HOLDINGS, INC.
  • Pfizer
  • Pharmaceutical Product Development, LLC (PPD)
  • PRA Health Sciences
  • Central Drugs Standard Control Organization (CDSCO)
  • Department of Health and Family Welfare
  • European Commission
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • Indian Drug Manufacturer's Association (IDMA)
  • International Society of Pharmaceutical Engineering (IPSE)
  • Korea Food and Drug Administration (KFDA)
  • Korea Pharmaceutical Manufacturer's Association (KPMA)
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Ministry of Health (MOH)
  • Ministry of Health, Labor and Welfare (MHLW)
  • Ministry of Industry and Information Technology (MIIT)
  • Pharmaceutical and Medical Devices Agency (PMDA)
  • World Health Organization (WHO)